8-methoxymethyl-3-isobutyl-1-methylxanthine has been researched along with cilostazol in 3 studies
| Studies (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Trials (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Recent Studies (post-2010) (8-methoxymethyl-3-isobutyl-1-methylxanthine) | Studies (cilostazol) | Trials (cilostazol) | Recent Studies (post-2010) (cilostazol) |
|---|---|---|---|---|---|
| 33 | 0 | 13 | 1,508 | 302 | 848 |
| Protein | Taxonomy | 8-methoxymethyl-3-isobutyl-1-methylxanthine (IC50) | cilostazol (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 10 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.4367 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.3285 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Akama, T; Baker, SJ; Freund, Y; Hernandez, V; Kimura, R; Maples, KR; Plattner, JJ; Sanders, V; Zhang, YK; Zhou, H | 1 |
| Kawasaki, T; Kobayashi, Y; Nakamura, H; Oki, Y; Shimizu, E; Yoshimi, T | 1 |
3 other study(ies) available for 8-methoxymethyl-3-isobutyl-1-methylxanthine and cilostazol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatitis, Atopic; Dermatologic Agents; Edema; Humans; Mice; Psoriasis; Structure-Activity Relationship; U937 Cells | 2009 |
OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Actins; Animals; Cell Differentiation; Cell Division; Cells, Cultured; Cilostazol; Culture Media; Cyclic AMP; Desmin; Dose-Response Relationship, Drug; Isoenzymes; Liver; Male; Muscle, Smooth; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles; Xanthines | 1999 |